EC Number |
Title |
Organism |
---|
6.1.1.20 | Chimeric human mitochondrial PheRS exhibits editing activity to discriminate nonprotein amino acids |
Homo sapiens |
6.1.1.20 | High throughput screen identifies natural product inhibitor of phenylalanyl-tRNA synthetase from Pseudomonas aeruginosa and Streptococcus pneumoniae |
Streptococcus pneumoniae |
6.1.1.20 | High throughput screen identifies natural product inhibitor of phenylalanyl-tRNA synthetase from Pseudomonas aeruginosa and Streptococcus pneumoniae |
Pseudomonas aeruginosa |
6.1.1.20 | Inhibitory effects on silk fibroin production by the expression of phenylalanyl-tRNA synthetase mutants in posterior silk glands of Bombyx mori |
Bombyx mori |
6.1.1.20 | Kinetic and structural changes in HsmtPheRS, induced by pathogenic mutations in human FARS2 |
Homo sapiens |
6.1.1.20 | Molecular polygamy The promiscuity of L-phenylalanyl-tRNA-synthetase triggers misincorporation of meta- and ortho-tyrosine in monoclonal antibodies expressed by Chinese hamster ovary cells |
Cricetulus griseus |
6.1.1.20 | Multiple quality control pathways limit non-protein amino acid use by yeast cytoplasmic phenylalanyl-tRNA synthetase |
Saccharomyces cerevisiae |
6.1.1.20 | Tailoring the substrate specificity of yeast phenylalanyl-tRNA synthetase toward a phenylalanine analog using multiple-site-specific incorporation |
Saccharomyces cerevisiae |
6.1.1.20 | The role of a novel auxiliary pocket in bacterial phenylalanyl-tRNA synthetase druggability |
Escherichia coli |
6.1.1.20 | The role of a novel auxiliary pocket in bacterial phenylalanyl-tRNA synthetase druggability |
Pseudomonas aeruginosa |